Towards Global HPV Eradication: Single-Dose HPV Vaccination vs. Pseudoscience

Area of Science:

• Virology
• Immunology
• Public Health

Background:

• Human papillomavirus (HPV) is a primary cause of cervical cancer.
• Global viral eradication requires specific criteria, including effective vaccines and a single host species.
• Vaccine hesitancy, fueled by misinformation, hinders eradication efforts for diseases like measles and HPV.

Purpose of the Study:

• To highlight the potential for global eradication of high-risk HPV types through vaccination.
• To address and scientifically refute alleged adverse events associated with HPV vaccination, such as HANS.
• To advocate for the implementation of single-dose and gender-neutral HPV vaccination strategies.

Main Methods:

• Review of scientific literature on HPV, vaccine efficacy, and adverse event claims.
• Analysis of the criteria for autoimmune diseases (Witebsky's postulates) in relation to HANS.
• Evaluation of computational and experimental evidence regarding molecular mimicry and aluminum adjuvants.

Main Results:

• HPV is an ideal candidate for eradication due to its human-specific nature and vaccine efficacy.
• Mice vaccinated with a single HPV dose produced anti-HPV antibodies without prolonged pro-inflammatory cytokine profiles.
• Scientific evaluation found no evidence supporting HANS as a novel autoimmune disease or implicating aluminum adjuvants; existing HANS models were flawed.

Conclusions:

• Worldwide implementation of HPV vaccination, including single-dose and gender-neutral approaches, can globally eliminate high-risk HPV types.
• Denouncing pseudoscientific claims is crucial for successful HPV vaccination programs.
• Rigorous scientific evaluation confirms the safety and efficacy of HPV vaccines, countering misinformation.